Last update 20 Jun 2024

Secnidazole

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
1-(2-methyl-5-nitro-1H-imidazol-1-yl) propan-2­ ol, 1-(2­ hydroxypropyl)-2-methyl-5-nitroimidazole, Secnidazole (USAN/INN)
+ [15]
Target-
Mechanism
DNA synthesis inhibitors
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
CH (01 Jan 1980),
RegulationFast Track (US)
Login to view First Approval Timeline

Structure

Molecular FormulaC7H11N3O3
InChIKeyKPQZUUQMTUIKBP-UHFFFAOYSA-N
CAS Registry3366-95-8

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Giardiasis
CN
16 May 2000
Trichomonas Infections
CN
16 May 2000
Bacterial Vaginosis
CH
-01 Jan 1980
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2/3
24
jgugphzziy(kblwvskuks) = qufrsdnphw wdgvngpxmx (bwbicnxmbw, tiuhtndayf - yofwbaykwf)
-
05 Feb 2024
Phase 3
147
Placebo
(Placebo)
ewijkqcnik(doxfybggjr) = mrwyfsmvxy zmdhugvmwc (ykzihysnkb, wwjkujqzon - thsacdpptt)
-
04 Oct 2023
(Solosec (Containing 2 Grams of Secnidazole))
jvztnyjaaj(rfcurahohs) = aiyaujjuhh vktuuyrouz (iekntmvlha, xbitsqphsy - txfeetitti)
Phase 3
147
jptmehsxjw(hayriskutn) = xehnarddfk cgaqjffldk (kxyptigxnh )
Positive
15 Sep 2021
Placebo
jptmehsxjw(hayriskutn) = qqhunasqnd cgaqjffldk (kxyptigxnh )
Phase 3
189
(SYM-1219)
prukhhjyzm(pcxpjgvcod) = vlajwiowub exehmlgytj (dsskqjecap, oythomxzmy - hmanavivwl)
-
13 Apr 2021
Placebo
(Placebo)
prukhhjyzm(pcxpjgvcod) = ryjhxcwski exehmlgytj (dsskqjecap, wimkafktdf - dzxfqnimzl)
Phase 3
325
ctkkwdqokt(jvjizgljco) = wwnfuaxlhn yzquyijyqw (qpijohzfev, dynadqsmzu - wvqneeasfp)
-
13 Apr 2021
Phase 3
283
ebdlumtegl(ignpzfowwn) = vulvovaginal mycotic infection 5.3%, nausea 4.4%, and dysgeusia 3.1% xjxpvibrsz (kqmdqhulgp )
Positive
01 Apr 2018
Phase 2
215
(SYM-1219 Low Dose)
xiolstjkjz(bhnpiuffdy) = tpmoyqbtof zxoslpartz (zgmdzdalbn, iezapxemxy - eoxjbcdpve)
-
14 Dec 2017
(SYM-1219 High Dose)
xiolstjkjz(bhnpiuffdy) = fyjcmyayuf zxoslpartz (zgmdzdalbn, iwfeurvizj - jatherllzb)
Phase 3
189
zvnfbejzvk(ywfiqaziys) = sooysglsoa xbjteslorx (cszpagzvlh )
Positive
01 Dec 2017
Placebo
zvnfbejzvk(ywfiqaziys) = xpmckxzibp xbjteslorx (cszpagzvlh )
Phase 2
215
lejtianokc(xsdhbsfeyq) = ddaxhvfwta ldlnixafqu (doeauejhby )
Positive
01 Aug 2017
lejtianokc(xsdhbsfeyq) = kwmosyhbvg ldlnixafqu (doeauejhby )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free